BeiGene | Study of Bcl-2 Inhibitor BGB-11417 in Participants With Mature B-Cell Malignancies

⟵ Back to Search Results

Study of Bcl-2 Inhibitor BGB-11417 in Participants With Mature B-Cell Malignancies

Beigene Study ID

BGB-11417-101

ClinicalTrials.gov ID

NCT04277637

Study Overview

Sex: All

Age: 18 Years / N/A

Accepts Healthy Volunteers? yes

No Study Documents

Locations

Study Overview

Sex: All

Age: 18 Years / N/A

Accepts Healthy Volunteers? yes

No Study Documents